A chemiluminescence-based GH assay with 30- to 100-fold increased sensitivity recently disclosed combined basal and pulsatile GH secretion in men. However, how age, sex steroid hormones, and obesity singly and jointly influence the basal vs. pulsatile modes of GH release is not known. We used the foregoing assay (detection threshold, 0.002-0.005 microgram/L) and high sensitivity and specificity (> or = 90% each) deconvolution analysis to quantitate basal and pulsatile GH secretion from 24-h serum GH concentration profiles in 26 healthy lean and obese men, whose ages spanned 18-63 yr and whose percentage body fat ranged from 12-47%. Concentrations of serum insulin-like growth factor I (IGF-I), IGF-I-binding protein-1 (IGFBP-1), and IGFBP-3 were related to specific measures of basal or pulsatile GH release. We observed that mean (24-h) serum GH concentrations embraced a 140-fold range from 0.013-1.8 micrograms/L and were related negatively to age (r = -0.50; P < 0.01), percentage body fat (r = -0.620; P < 0.01), and their interaction (r = -0.610; P < 0.01). In contrast, testosterone was a robustly positive statistical determinant of mean serum GH values (r = 0.628; P = 0.0006). Stepwise multivariate regression analysis disclosed that percentage body fat alone and jointly with the serum testosterone concentration controlled, respectively, 38% and 50% of the total variability in GH levels (P = 0.0013 and P = 0.0008). As assessed by deconvolution analysis, GH secretory burst mass was negatively related to percentage body fat (r = -0.621; P < 0.01) and positively to serum testosterone (r = 0.529; P = 0.0054). The calculated half-life of GH correlated positively with serum estradiol (r = 0.447; P = 0.032), and negatively with percentage body fat (r = -0.437; P = 0.048). Basal GH secretion rates were negatively related to serum estradiol (r = -0.485; P = 0.016). In contrast, GH secretory burst frequency and duration were unrelated to age, percentage body fat, or sex steroids. The fraction of total GH secreted in bursts was negatively correlated with the body mass index (r = -0.540; P < 0.01). Serum IGF-I concentrations were positively related to total pulsatile GH secretion (r = 0.690; P = 0.0011) and negatively to age (r = -0.597; P = 0.007) and percentage body fat (r = -0.611; P = 0.009). Serum IGFBP-3 was inversely proportional to the basal GH secretion rate (r = -0.467; P = 0.044). In contrast, IGFBP-1 concentrations correlated positively with GH secretory burst mass (r = 0.674; P = 0.0016) as well as basal GH secretion (r = 0.519; P = 0.023), and negatively with age, and percentage body fat and their interactions (absolute r values 0.517-0.653; P ≤ 0.021). The serial orderliness of GH release, as assessed by a novel approximate entropy CApEn) statistic, revealed decreased orderliness (higher ApEn) of GH release with increasing age (r = 0.482; P = 0.019) and adiposity (r = 0.505; P = 0.014). In contrast, the patterned regularity of GH release rose (lower ApEnl with higher serum testosterone concentrations (r = -0.405; P = 0.048). In summary, we infer that in healthy men, 1) basal and pulsatile GH secretion may be regulated differentially by estradiol and testosterone, respectively; 2) basal and pulsatile GH release may influence serum IGF-1, IGFBP-3, and IGFBP-1 concentrations in distinct ways; and 3) the serial regularity or orderliness of GH release is negatively related to age and obesity, but positively to the serum androgen concentration. Accordingly, we hypothesize that 1) distinct neuroendocrine regulatory mechanisms govern basal vs. pulsatile GH secretion; 2) GH target tissue responses, as reflected by serum IGF-I, IGFBP-3, and IGFBP-1 concentrations, are controlled by the specific temporal mode (basal vs. pulsatile) of GH release; and 3) the reproducibility of GH release patterns (estimated by an approximate entropy statistic) in normal men is modulated by key physiological variables (age, body composition, and serum testosterone concentrations), which, therefore, probably act to coordinate hypothalamic somatostatin and GHRH secretion temporarily.
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Clinical Biochemistry
- Biochemistry, medical